Work

Engineered E. coli for the targeted deposition of therapeutic payloads to sites of disease

Year: 2022

Type: preprint

Source: Research Square

DOI: 10.21203/rs.3.rs-1233122/v1

Authors: Jason Lynch, Coral Coral González-Prieto, Analise Reeves, Urmila Powale, Neha Godbole, Jacqueline Tremblay, Florian Schmidt, Hidde Ploegh, Jonathan Glickman, John Leong, Charles Shoemaker, Wendy Garrett, CAMMIE LESSER

Institutions: Harvard University, Massachusetts General Hospital, Tufts University, Boston Children's Hospital, Beth Israel Deaconess Medical Center, University of Bonn, Synlogic (United States), Broad Institute, Dana-Farber Cancer Institute

Language: English

Topic: Cancer Research and Treatments

Subfield: Biotechnology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Massachusetts General Hospital, Kenneth Rainin Foundation, National Institutes of Health

Awards: G9000171934, G9000257679

OpenAlex ID: W4206950865

Cites: 57

Cited by: 2

Related to: 10